Wide Excision or Mohs Micrographic Surgery for the Treatment of Primary Dermatofibrosarcoma Protuberans
- 1 June 2010
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 33 (3) , 300-303
- https://doi.org/10.1097/coc.0b013e3181aaca87
Abstract
Dermatofibrosarcoma protuberans (DFSP) is a spindle cell tumor with a high local recurrence rate. Wide excision (WE) has been the standard treatment, but ideal margin width is poorly defined and Mohs micrographic surgery (MMS) has emerged as an alternative procedure. This study examines the use of WE versus MMS for the treatment of primary DFSP at a single institution. Retrospective review of 48 primary DFSP cases treated from 1971 to 2006. Patient demographics, tumor features, surgical modality (WE vs. MMS), final pathology, and clinical outcome were evaluated. Twenty-eight patients underwent WE versus 20 patients for MMS. Median age was 40 years. Median WE margin width was 2 cm. For MMS, the median number of layers required to clear the tumor was 2. Median maximal defect size was 10 cm for WE versus 9.4 cm for MMS. Advanced closure techniques were required for 18% WE versus 65% MMS (P = 0.001). Median operative time was significantly lower for WE at 77 minutes versus 257 minutes for MMS (P < 0.001). Positive margins were present in 21.4% (6/28) WE versus 0% MMS (P = 0.01). At a median follow-up of 49.9 months for WE and 40.4 months for MMS, local recurrence rates were 3.6% (1/28) and 0%, respectively (P = 1.0). From a surgical standpoint, WE was faster than MMS and resulted in a less complex defect/closure. Although positive margin resection was more common with WE, local control was ultimately similar for the 2 surgical modalities. The choice of WE versus MMS should be based on individualized patients/tumor characteristics and institutional expertise in these modalities.Keywords
This publication has 24 references indexed in Scilit:
- Surgical Treatment for Dermatofibrosarcoma ProtuberansAnnals of Plastic Surgery, 2008
- Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002Journal of the American Academy of Dermatology, 2007
- Dermatofibrosarcoma protuberansCancer, 2004
- Outcomes of surgery for dermatofibrosarcoma protuberansEuropean Journal of Surgical Oncology, 2004
- Dermatofibrosarcoma Protuberans of the Head and Neck: Treatment With Mohs Surgery Using Inverted Horizontal Paraffin SectionsThe Laryngoscope, 2003
- Dermatofibrosarcoma Protuberans: Surgical Treatment OptionsSKINmed: Dermatology for the Clinician, 2003
- Dermatofibrosarcoma protuberansCancer, 2000
- Dermatofibrosarcoma protuberans: what is the best surgical approach?Surgical Oncology, 1999
- Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1997
- Dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1996